false
0001512228
A1
0001512228
2025-09-26
2025-09-26
0001512228
NB:CommonSharesWithoutParValueMember
2025-09-26
2025-09-26
0001512228
NB:WarrantsEachExercisableFor1.11829212CommonSharesMember
2025-09-26
2025-09-26
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): September 26, 2025
NioCorp Developments Ltd.
(Exact name of registrant as specified in its charter)
British Columbia, Canada
(State or other jurisdiction
of incorporation) |
001-41655
(Commission File Number) |
98-1262185
(IRS Employer
Identification No.) |
7000 South Yosemite Street, Suite 115
Centennial, Colorado 80112
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area
code: (720) 334-7066
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common Shares, without par value |
NB |
The Nasdaq Stock Market LLC |
| Warrants, each exercisable for 1.11829212 Common Shares |
NIOBW |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
| Item 1.01 | Entry into a Material Definitive Agreement. |
Placement Agency Agreement
On September 26, 2025, NioCorp Developments Ltd.
(the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group
LLC to act as the Company’s exclusive placement agent (the “Placement Agent”) to solicit offers to purchase common shares,
without par value, of the Company (the “Common Shares”) (or pre-funded warrants (the “Pre-Funded Warrants”) to
purchase Common Shares in lieu thereof) in a public offering registered under the Securities Act (as defined below) (the “Offering”).
Pursuant to the Placement Agency Agreement, the Company issued and sold (a) 7,004,740 Common Shares at a public offering price of $6.15 per Common
Share, less the Placement Agent’s fee of $0.4305 per Common Share, and (b) 2,755,260 Pre-Funded Warrants at a public offering price
of $6.1499 per Pre-Funded Warrant, less the Placement Agent’s fee of $0.4305 per Pre-Funded Warrant. The Offering was conducted
on a reasonable “best efforts” basis and closed on September 29, 2025.
Each Pre-Funded Warrant is exercisable for one
Common Share at a price per Common Share of $0.0001. The Pre-Funded Warrants may be exercised at any time on or after the date of issuance
and do not have an expiration date. The Pre-Funded Warrants contain provisions that prohibit exercise if the holder, together with its
affiliates, would beneficially own more than 4.99%, or 9.99% upon notice by the holder, of the number of Common Shares outstanding immediately
after giving effect to such exercise. A holder of Pre-Funded Warrants may increase or decrease this percentage to a percentage not in
excess of 9.99% by providing notice to the Company, which increase will not be effective until at least 61 days following such notice.
Pre-Funded Warrant holders will not have the rights or privileges of a holder of Common Shares with respect to the Common Shares underlying
such Pre-Funded Warrants, including any voting rights, until the holder exercises such Pre-Funded Warrants. There is no established trading
market for the Pre-Funded Warrants and the Company does not expect a market to develop. In addition, the Company does not intend to apply
for the listing of the Pre-Funded Warrants on any national securities exchange or other trading market.
The Placement Agency Agreement contains customary
representations, warranties and covenants made by the Company. It also provides customary indemnification by each of the Company and the
Placement Agent for losses or damages arising out of or in connection with the Offering, including for liabilities under the Securities
Act of 1933, as amended (the “Securities Act”). Pursuant to the Placement Agency Agreement, the Placement Agent will have
a right of first refusal to act as sole managing underwriter and sole book runner, sole placement agent, or sole sales agent, for any
and all future public or private equity, equity-linked or convertible debt offerings for which the Company retains the services of an
underwriter, agent, advisor or finder until November 14, 2025.
In addition, pursuant to the terms of the Placement
Agency Agreement, the Company’s executive officers and directors entered into lock-up agreements in substantially the form included
as an exhibit to the Placement Agency Agreement, providing for a 30-day “lock-up” period with respect to sales of Common Shares
and securities that are exchangeable or exercisable for Common Shares, subject to certain exceptions. In addition, subject to certain
exceptions, the Company has agreed, (i) for a period of 60 days following the date of the closing of the Offering, not to, and to cause
its subsidiaries not to, issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Shares or
any securities that are convertible into, or exchangeable or exercisable for, Common Shares and (ii) for a period of 60 days following
the date of the closing of the Offering, issue any securities that are subject to a price reset based on the trading prices of our Common
Shares or upon a specified or contingent event in the future, or enter into any agreement to issue securities at a future determined price.
The foregoing restrictions may be waived by the Placement Agent at its discretion.
The Offering was made pursuant to the Company’s
effective registration statement on Form S-3 (File No. 333-280176) (the “Registration Statement”), which was filed with the
Securities and Exchange Commission (the “SEC”) on June 13, 2024 and declared effective by the SEC on June 27, 2024, as supplemented
by a prospectus supplement, dated September 26, 2025, filed with the SEC on September 29, 2025.
The net proceeds from the Offering were approximately
$55.3 million, after deducting the Placement Agent commissions and estimated offering expenses but before giving effect to the exercise
of any Pre-Funded Warrants.
The foregoing description of the Placement Agency
Agreement is qualified in its entirety by the full text of the Placement Agency Agreement, a copy of which is filed as Exhibit 1.1 to
this Current Report on Form 8-K and is incorporated herein by reference. The foregoing description of the Pre-Funded Warrants is qualified
in its entirety by the full text of the Form of Pre-Funded Warrant, a copy of which is filed as Exhibit 4.1 to this Current Report on
Form 8-K and is incorporated herein by reference.
| Item 7.01 | Regulation FD Disclosure. |
On September 29, 2025, the Company issued a press release announcing the closing of the Offering. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Such exhibit and the information set forth therein shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed
to be incorporated by reference in any filing under the Securities Act or the Exchange Act.
The Company is filing herewith the following
exhibits to the Registration Statement:
| 1. | Placement Agency Agreement, dated as of September 26, 2025, by and between NioCorp Developments Ltd. and
Maxim Group LLC; |
| 2. | Form of Pre-Funded Warrant; |
| 3. | Opinion and Consent of Blake, Cassels & Graydon LLP; and |
| 4. | Opinion and Consent of Jones Day. |
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit
Number |
Description |
| 1.1 |
Placement Agency Agreement, dated as of September 26, 2025, by and between NioCorp Developments Ltd. and Maxim Group LLC |
| 4.1 |
Form of Pre-Funded Warrant (included in Exhibit 1.1) |
| 5.1 |
Opinion of Blake, Cassels & Graydon LLP |
| 5.2 |
Opinion of Jones Day |
| 23.1 |
Consent of Blake, Cassels & Graydon LLP (included in Exhibit 5.1) |
| 23.2 |
Consent of Jones Day (included in Exhibit 5.2) |
| 99.1 |
Press Release, dated September 29, 2025 |
| 104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
NIOCORP DEVELOPMENTS LTD. |
| |
|
|
| Dated: September 29, 2025 |
By: |
/s/ Neal S. Shah |
| |
Name: |
Neal S. Shah |
| |
Title: |
Chief Financial Officer |
